Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-12-16
2008-03-04
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S135000
Reexamination Certificate
active
07338968
ABSTRACT:
Disclosed are novel compounds of the formula:and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.
REFERENCES:
patent: 3115495 (1963-12-01), Wright
patent: 3115496 (1963-12-01), Wright
patent: 4170588 (1979-10-01), Hegenberg et al.
patent: 4394508 (1983-07-01), Crenshaw et al.
patent: 4497810 (1985-02-01), Hoffman
patent: 4510309 (1985-04-01), Crenshaw et al.
patent: 4532246 (1985-07-01), Ife
patent: 4532252 (1985-07-01), Sach
patent: 4562184 (1985-12-01), Baldwin et al.
patent: 4607106 (1986-08-01), Ife
patent: 4639523 (1987-01-01), Nohara et al.
patent: 4640926 (1987-02-01), Sach
patent: 4659725 (1987-04-01), Ife
patent: 4663331 (1987-05-01), Brown et al.
patent: 4732980 (1988-03-01), Brown et al.
patent: 4863936 (1989-09-01), Sach
patent: 5206252 (1993-04-01), Butera et al.
patent: 5354763 (1994-10-01), Butera et al.
patent: 5397790 (1995-03-01), Butera et al.
patent: 5401753 (1995-03-01), Butera et al.
patent: 5403853 (1995-04-01), Butera et al.
patent: 5466712 (1995-11-01), Butera et al.
patent: 5494925 (1996-02-01), Court et al.
patent: 5506252 (1996-04-01), Butera et al.
patent: 5532245 (1996-07-01), Butera et al.
patent: 5550139 (1996-08-01), Groutas
patent: 5840764 (1998-11-01), Quagliato et al.
patent: 5958957 (1999-09-01), Andersen et al.
patent: 5962535 (1999-10-01), Miyamoto et al.
patent: 5972978 (1999-10-01), Andersen et al.
patent: 6063800 (2000-05-01), Andersen et al.
patent: 6080770 (2000-06-01), Andersen et al.
patent: 6300325 (2001-10-01), Widdowson et al.
patent: 6376555 (2002-04-01), Butera et al.
patent: 6420396 (2002-07-01), Albers et al.
patent: 6498161 (2002-12-01), Caldwell et al.
patent: 6878709 (2005-04-01), Taveras et al.
patent: 6903131 (2005-06-01), Taveras et al.
patent: 7132445 (2006-11-01), Taveras et al.
patent: 2001/0018447 (2001-08-01), Widdowson et al.
patent: 2003/0204085 (2003-10-01), Taveras et al.
patent: 2004/0034229 (2004-02-01), Taveras et al.
patent: 2004/0053953 (2004-03-01), Taveras et al.
patent: 2004/0063709 (2004-04-01), Taveras et al.
patent: 2004/0186142 (2004-09-01), Taveras et al.
patent: 2006/0025453 (2006-02-01), Taveras et al.
patent: 33 09 655 (1984-09-01), None
patent: 0 040 696 (1981-12-01), None
patent: 0 067 436 (1982-12-01), None
patent: 0 099 121 (1984-01-01), None
patent: 0 099 121 (1984-01-01), None
patent: 0 275 997 (1988-07-01), None
patent: 0 376 079 (1990-07-01), None
patent: 0 796 243 (1999-01-01), None
patent: 1186906 (1970-04-01), None
patent: 2124622 (1984-02-01), None
patent: 2132190 (1984-07-01), None
patent: WO94/29277 (1994-12-01), None
patent: WO95/14005 (1995-05-01), None
patent: WO96/14300 (1996-05-01), None
patent: WO96/15103 (1996-05-01), None
patent: WO98/33763 (1998-08-01), None
patent: WO 00/20378 (2000-04-01), None
patent: WO 00/21927 (2000-04-01), None
patent: WO 00/35855 (2000-06-01), None
patent: WO 00/35864 (2000-06-01), None
patent: WO 00/73260 (2000-12-01), None
patent: WO 00/76501 (2000-12-01), None
patent: WO 01/28987 (2001-04-01), None
patent: WO 01/29000 (2001-04-01), None
patent: WO 01/64208 (2001-09-01), None
patent: WO 01/64691 (2001-09-01), None
patent: WO 01/68569 (2001-09-01), None
patent: WO 01/92202 (2001-12-01), None
patent: WO 02/057230 (2002-07-01), None
patent: WO 02/067919 (2002-09-01), None
patent: WO 02/076926 (2002-10-01), None
patent: WO 02/083624 (2002-10-01), None
patent: WO 03/031440 (2003-04-01), None
patent: WO 03/057676 (2003-07-01), None
patent: WO 03/080053 (2003-10-01), None
patent: WO 2004/033440 (2004-04-01), None
Schostarez et al., “Cyanoguanidine Bioisosteres In Potassium Channel Openers: Evaluation of 3,4-Disubstituted-1,2,5-Thiadiazole-1-Oxides,” Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 18, pp. 2187-2192 (1996).
Chemcial Abstract 66:18527 for Maahs, Guenther, et al., “Syntheses and derivatives of squaric acid”,Angewandte Chemie78(20:927-31 (1966) (which is attached to said abstract).
Chemical Abstract 87:134383 for Augustin, Manfred, et al., “Disubstitution in 2,3-dichloromaleimides”Zeitschrift Fuer Chemie17(6):215-216 (1977) (which is attached to said abstract).
Chemical Abstract No. 87:151727 for Ehrhardt, Heinz, et al., “Amides and thioamides of squaric acid: syntheses and reactions,”Chemische Berichie110(7):2506-23 (1977) (which is attached to said abstract).
AN 1984-238224 and AN 1985-24633 abstracts (in English) for DE33 09 655.
Chemical Abstract 104:129517 for Gruenefeld, Johann, et al., “Reactions of squaric acid with carbodilmides,”Archiv der Pharmazie318(12):1062-70 (1985) (which is attached to said abstract).
Chemical Abstract No. 122:160745 for Tillack, Annegret, et al., Assymmetric catalysis. IV. Hydrosilylation of acetophenone with pyrroline-2,5-dione modified [Rh(COD)C1]2 catalystJournal of Organometalolic Chemistry482:85-91 (1994) (which is attached to said abstract).
Chemical Abstract No. 125:300482 for Chen, Yizhao, et al., “Reaction of dibutyl oxosquarate with aromatic primary amines,”Sichuan Daxue Xuebao, Ziran Kexueban33(2):182-186 (1996) (which is attached to said abstract).
Chemical Abstract No. 130:222994 for Chen, Yi-Zhao, et al., “Synthesis of asymmetric arylsubstituted amides of squaric acid and asymmetric isosquarylium amides”,Hechen Huaxue6(4):383-392 (1998) (which is attached to said abstract).
Butera, John A., et al., “Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 1. N-Cyanoguanidine Bioisosteres Possessing in Vivo Bladder Selectivity”,J. Med. Chem.43:1187-1202 (2000).
Davis, Peter D., et al., “Inhibitors of Protein Kinase C 11. 2,3-Bisarylmaleimides”, J.Med. Chem.35:177-184 (1992).
Hanaineh-Abdelnour, Leila, et al., “Some synthetic applications of 2,3-Dichloro-N-phenylmaleimide: A Novel Synthesis of 2-Phenylpyrrolo[3,4-b]quinoxaline-1,3-diones. I”,Tetrahedron55:11859-11870 (1999).
Hoffman, Jacob M., et al., “Conformational Requirements of Histamine H2-Receptor Inhibitors: Structure-Activity Study of Phenylene Analogues Related to Cimetidine and Tiotidine”,Journal of Medicinal Chemistry26(2):140-44 (1983).
Karady, Sandor, et al., “1,2,5-Thiadiazole-1-Oxides.I.Synthesis and Reactions of Alkoxy and Alkythio Analogs”,Heterocycles16(9): 1561-4 (1981).
Martinez, Ana, et al., “Synthesis of Nonsymmetrically 3,4-Disubstituted 1,2,5-Thiadiazole Dioxides”,Journal of Heterocyclic Chemistry35(2):297-300 (1998).
Neuse, Eberhard W.., et al., Poly(squaryl amides):Polymer15:339-45 (1974).
Patent Abstracts of Japan, vol. 018, No. 361 (c-1222), Jul. 7, 1994 and JP 06092915A, Apr. 5, 1994 abstract.
Schostarez, Heinrich J., et al., “Cyanoguanidine Bioisosteres in Potassium Channel Openers: Evaluation of 3,4-Disubstituted-1,2,5-Thiadiazole-1-Oxides”,Bioorganic&Medicinal Chemistry Letters6(18):2187-92 (1996).
Wen, Richard Y., et al., “The Chemistry of 1,2,5-Thiadiazoles. II. 3,4-Disubstituted Derivatives of 1,2,5-Thiadiazole 1,1-Dioxide,”J. Org. Chem.40(19):2743-8 (1975).
Zhou, Hai-Bing, et al., “Design, synthesis and structure of new chiral squaric acid monoaminoalcohols and diaminoalcohols and their use as catalysts in asymmetric reduction of ketones and diketones,”Tetrahedron57:9325-9333 (2001).
U.S. Appl. No. 10/390,078, filed Mar. 17, 2003.
U.S. Appl. No. 10/630,258, filed Jul. 30, 2003.
PCT International Search Report dated Mar. 31, 2004 for corresponding PCT Ap
Aki Cynthia J.
Baldwin John J.
Biju Purakkattle J.
Chao Jianhua
Merritt J. Robert
Anderson Rebecca
Freistein Andrew B.
Jeanette Henry C.
Schering Corporation
LandOfFree
Thiadiazoles AS CXC- and CC- chemokine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiadiazoles AS CXC- and CC- chemokine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiadiazoles AS CXC- and CC- chemokine receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3979279